Neuronetics, Inc.

Neuronetics, Inc. announced on 19 July the US Food and Drug Administration cleared its NeuroStar transcranial magnetic stimulation system (TMS) for anxious depression based on results from a real-wor

As people everywhere continue to face uncertainties and challenges during the COVID-19 pandemic, rates of depression, anxiety and feelings of hopelessness are also on the rise. According to a poll by

As people everywhere continue to face uncertainties and challenges during the COVID-19 pandemic, rates of depression, anxiety and feelings of hopelessness are also on the rise. According to a poll by

The razor-razor blade business model is pervasive in the medtech industry. As the conventional wisdom, it has a compelling logic. Each equipment placement leads to a lengthy revenue annuity. For examp